1. Impact of contrast-enhanced CT in the dosimetry of SBRT for liver metastases treated with MR-Linac
- Author
-
Min Liu, Mingzhe Liu, Feng Yang, Yanhua Liu, Shoulong Wang, Yazhen Chen, Jie Li, Xianliang Wang, and Lucia Clara Orlandini
- Subjects
MR-Linac ,Contrast media ,Liver cancer ,SBRT ,Synthetic CT ,MR guided adaptive radiotherapy ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background To investigate the impact of using contrast-enhanced computed tomography (CHCT) in the dosimetry of stereotactic body radiation therapy (SBRT) for liver metastases treated with MR-Linac. Methods A retrospective study was conducted on 21 liver cancer patients treated with SBRT (50 Gy in 5 fractions) using a 1.5 Tesla Unity MR-Linac. The clinical treatment plans optimised on plain computed tomography (pCT) were used as reference. The electronic density (ED) of regions of interest (ROIs) including the liver, duodenum, esophagus, spinal cord, heart, ribs, and lungs, from pCT and CHCT, was analysed. The average ED of each ROI from CHCT was used to generate synthetic CT (sCT) images by assigning the average ED value from the CHCT to the pCT. Clinical plans were recalculated on sCT images. Dosimetric comparisons between the original treatment plan (TPpCT) and the sCT plan (TPsCT) were performed using dose-volume histogram (DVH) parameters, and gamma analysis. Results Significant ED differences (p
- Published
- 2024
- Full Text
- View/download PDF